The European Union (EU) announced that it is starting the German CureVac coronavirus vaccine’s evaluation process.
Norway has an agreement for around two million doses of the vaccine in 2021, according to the National Institute of Public Health (FHI).
“We hope for a quick approval process of the CureVac vaccine to ensure Norway gets access to even more vaccine doses,” infection control director Geir Bukholm at the FHI noted.
The CureVac vaccine, like the Moderna and BioNTech / Pfizer vaccines, is a so-called mRNA vaccine.
However, it is easier to distribute and store than the others, as it can be stored at refrigerator temperature for three months, and at room temperature for 24 hours.
Source: © NTB Scanpix / #Norway Today / #NorwayTodayNews
Do you have a news tip for Norway Today? We want to hear it. Get in touch at email@example.com